SCHEMBL22052045

SCHEMBL22052045

O=CNCc1ccc(CNC(=O)C2Cc3ccccc3C2)cc1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.52
ALDH1A1 P00352 3/20 0.50
USP2 O75604 1/20 0.50
HPGD P15428 1/20 0.50
ADH1B P00325 1/20 0.49
ADH1C P00326 1/20 0.49
ADH1A P07327 1/20 0.49
ADH7 P40394 1/20 0.49
BLM P54132 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MC4R P32245 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
EPHX2 P34913 1/20 0.42
LMNA P02545 1/20 0.42
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22456651 0.89 TP53 (0.60) TP53ALDH1A1USP2HPGDBLM
SCHEMBL5358067 0.82 ALDH1A1 (0.59) TP53ALDH1A1USP2HPGDSMN1; SMN2
SCHEMBL5358226 0.82 TP53 (0.57) TP53ALDH1A1USP2HPGDSMN1; SMN2
SCHEMBL5361142 0.80 SMN1; SMN2 (0.65) TP53ALDH1A1HPGDBLMSMN1; SMN2
SCHEMBL5358075 0.76 MCHR1 (0.51) TP53ALDH1A1USP2HPGDTSHR
SCHEMBL3455684 0.74 USP2 (0.50) TP53ALDH1A1USP2HPGDBLM
SCHEMBL24304646 0.74 ALDH1A1 (0.43) TP53ALDH1A1USP2HPGDADH1B
SCHEMBL1193938 0.74 NAMPT (0.45) TP53LMNA
SCHEMBL5373226 0.73 ALDH1A1 (0.52) TP53ALDH1A1USP2HPGDLMNA
SCHEMBL5354227 0.73 SRC (0.50) ALDH1A1USP2HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020110056-A1 COMPOUNDS USEFUL IN HIV THERAPY GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2020-06-04 WO disclosed